NCT06084520 Translation and Validation of the COMM and ASI-SR
| NCT ID | NCT06084520 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Uppsala University |
| Condition | Opioid Use |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2023-12-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2023-12-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to translate the COMM (Current opinion misuse measure) form and validate it using the ASI-SR (Addiction severity score-self report)in a Swedish population of pain patients treated with opioids. The secondary aim is to investigate acceptability of the instrument in a Swedish population of pain patients with long-term opioid treatment (LOT). The tertiary aim is to investigate the prevalence of alcohol and illicit substance use in a Swedish population of pain patients with LOT.
Eligibility Criteria
Inclusion Criteria: Intervention group: * Patients with long-term, non-cancer-related pain (\>3 months) at least 3 days a week * opioid treatment for at least 1 month during last 6 months * age 18-75 years * fluent in spoken and written Swedish. Control group: * Patients with long-term, non-cancer-related pain (\>3 months) at least 3 days a week * no opioid treatment at inclusion and during last 3 months * age 18-75 years * fluent in spoken and written Swedish Exclusion Criteria: * ongoing diseases or conditions that prevents the patient from completing to the study according to the doctor's assessment * serious cognitive disorder that makes answering the questions impossible. - - ongoing or treated cancer in the last 10 years * Insufficient knowledge of Swedish
Contact & Investigator
Rolf Karlsten, PhD
PRINCIPAL INVESTIGATOR
Uppsala University
Frequently Asked Questions
Who can join the NCT06084520 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Opioid Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06084520 currently recruiting?
Yes, NCT06084520 is actively recruiting participants. Contact the research team at lenka.katila@uu.se for enrollment information.
Where is the NCT06084520 trial being conducted?
This trial is being conducted at Uppsala, Sweden.
Who is sponsoring the NCT06084520 clinical trial?
NCT06084520 is sponsored by Uppsala University. The principal investigator is Rolf Karlsten, PhD at Uppsala University. The trial plans to enroll 400 participants.